Positioning Statement
Latest News

BIO Ventures for Global Health

Impacting global health through multi-stakeholder initiatives, high impact partnering, and alliance management

BVGH has a unique perspective: we look at the health problems facing developing countries and emerging markets through a dual lens with expertise in both global health and biopharmaceutical industry dynamics.

Four New WIPO Re:Search Collaborations Finalized in May

Four new collaborations were finalized under WIPO Re:Search in May, including one between Eisai and the Liverpool School of Tropical Medicine (LSTM). Under this agreement, Eisai will provide a set of inhibitors to the LSTM to examine inflammation induced by Plasmodium-infected red blood cell adherence to vascular endothelial cells. To learn about the other new collaborations, read the latest WIPO Re:Search Snapshot.

Merck Fellows Join BVGH for the Summer

Katherine Young and Nicole Buist, research scientists at Merck, begin their fellowships with BVGH in June. After two weeks with the BVGH team in Seattle, Katherine and Nicole will be hosted by research institutions in Cameroon, Ghana and Kenya. Learn more about BVGH’s Fellowship Programs.

BVGH Hosted Panel Sessions at the 2014 BIO International Convention

Jennifer Dent, president of BVGH, hosted two panel sessions at the Biotechnology Industry Organization’s (BIO) annual International Convention on June 25th in San Diego: The Changing Landscape of Industry’s Engagement in Global Health and Africa: The Next Biotech Frontier?.